Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Real-World Outcomes of Patients with Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab As First- or Later-Line Treatment

Sabine Schmid,Lisa Holer,Katrin Gysel,Kira-Lee Koster,Sacha I. Rothschild, Laura A. Boos, Lorenz Frehner, Sabine Cardoso Almeida,Christian Britschgi,Yannis Metaxas,Michael Mark,Patrizia Froesch,Wolf-Dieter Janthur, Anna Allemann,Christine Waibel, Catherine von der Muhll-schill,Martin Fruh,Laetitia A. Mauti

JTO CLINICAL AND RESEARCH REPORTS（2024）

Cited 0|Views5
Key words
Malignant pleural mesothelioma,Ipilimumab,Nivolumab,Real-world,Outcome
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined